徐廷珍 – 維基百科，自由的百科全書
徐廷珍（韓語： 서정진，羅馬化： Seo Jung-jin，1957年10月23日 — ），大韓民國企業家，曾經是韓國首富。 韓國製藥企業 賽特瑞恩 （ 英語 ： Celltrion ） 名譽 會長 ， 建國大學 校友。
Seo Jung-jin – Forbes
Seo Jung-jin is cofounder of Celltrion, a biopharmaceutical firm that makes drugs to treat cancer, influenza and rheumatoid arthritis, among others. With the success of biosimilars in South…
Seo Jung-jin (businessman) – Wikipedia
Seo Jung-jin (Korean: 서정진; born October 23, 1957 [2]) is a South Korean businessman. He is among the richest people in South Korea, with Forbes giving his December 2024 net worth as US$7.2 billion and ranking him the third richest in the country. [3]
Seo Jung-jin – Chairman of Celltrion Group
Seo Jung-jin is the chairman of Celltrion Group. He is transforming Celltrion from a biosimilar (biopharmaceutical generic drug) company into a new drug developer. He was born on October 23, 1957, in Cheongju, Chungcheongbuk-do.
徐廷珍 – 百度百科
徐廷珍（Seo Jung-Jin），韩国人。 2019福布斯全球亿万富豪榜排名181位。 2019福布斯韩国富豪榜排名第2位。 2021年4月，福布斯全球富豪榜发布，徐廷珍以142亿美元财富位列榜单第145名。
Jung Jin SEO – EY World Entrepreneur Of The Year™ 2024 Judges
Jung Jin SEO knew very little about science before founding Celltrion, now a multibillion-dollar global pharmaceutical company. After losing his job at an automaker, Jung Jin saw an opportunity to pivot his career when he heard a scientist speak about the future of medicine.
Seo Jung-jin: The Visionary Behind Celltrion's Success
Seo Jung-jin, a name synonymous with biopharmaceutical innovation, is a visionary entrepreneur who co-founded Celltrion, one of South Korea's most successful and influential biotech firms. His journey from humble beginnings to becoming the founder of a company that revolutionized the biotechnology and pharmaceutical industries is a …
Seo Jung-jin: Founder who needed loan sharks is now South Korea's …
Seo Jung-jin used to borrow money from loan sharks, pledging his organs to get much needed funds for his upstart drugmaker. Now he's the second-richest person in South Korea, trailing just Samsung Electronics Co.'s chairman.
Seo Jung-Jin Age, Net Worth, Family, Career, Achievements & More
Seo Jung-Jin, born on October 23, 1957, in Cheongju, South Korea, is a distinguished South Korean businessman renowned for co-founding Celltrion, a leading biopharmaceutical company specializing in the development of biosimilars.
Seo Jung-jin — Profile
Seo Jung-jin is cofounder of Celltrion, a biopharmaceutical firm that makes drugs to treat cancer, influenza and rheumatoid arthritis, among others. With the success of biosimilars in South Korea, his Celltrion has become a favorite among investors.
2025 Concert Tour Dates – Jin | Tickets 2025
Tickets On Sale Today And Selling Fast, Secure Your Seats Now. Hong Kong Tickets 2025. Compare Prices on the Worlds Largest Ticket Marketplace
Seo Jung-jin (businessman) – Wikipedia
Seo Jung-jin (Korean: 서정진; born October 23, 1957 [2]) is a South Korean businessman. He is among the richest people in South Korea, with Forbes giving his December 2024 net worth as US$7.2 billion and ranking him the third richest in the country …
Celltrion – Wikipedia
Celltrion, Inc. (Korean: 주식회사 셀트리온) is a biopharmaceutical company headquartered in Incheon, South Korea.Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. [2] Celltrion's founder, Seo Jung-jin, is the richest person in South Korea. [3] …
Jung Jin SEO – EY World Entrepreneur Of The Year™ 2024 Judges
Jung Jin SEO knew very little about science before founding Celltrion, now a multibillion-dollar global pharmaceutical company. After losing his job at an automaker, Jung Jin saw an opportunity to pivot his career when he heard a scientist speak about the future of …
전종서 (@wjswhdtj94) • Instagram photos and videos
1M Followers, 23 Following, 106 Posts – 전종서 (@wjswhdtj94) on Instagram: "" 🩹@yennyennyy 🩹
셀트리온 Celltrion
Jung-Jin Seo said, ''The launch of ZYMFENTRA in the U.S. this year will mark a key step amongst many groundbreaking scientific discoveries and milestones by leveraging our global competitiveness. Celltrion remains committed to pursuing its goal in promoting the health and well-being of patients."
Profile: Seo Jung-jin has sights on 'biosimilar' market
Seo Jung-jin, the chief executive of Celltrion, South Korea's leading biopharmaceutical company, has made a strong career comeback. He lost his job in 1999 as a high-flying executive at the now …
A Conversation with Celltrion Group Chairman Mr. Jung-jin Seo
Jung-jin Seo, Chairman of Celltrion Group, a leading Korean biopharmaceutical company, joins The Korea Society's President, Tom Byrne for a conversation on the race to develop antibody treatments for the COVID-19 virus. Together, they will discuss the role of …
Jung Jin Seo, Celltrion Pharm Inc: Profile and Biography
Jung Jin Seo is Co-Chairman/Executive Director at Celltrion Pharm Inc. See Jung Jin Seo's compensation, career history, education, & memberships. Skip To Content
Seo Jung-jin – Chairman of Celltrion Group
Seo Jung-jin is the chairman of Celltrion Group. He is transforming Celltrion from a biosimilar (biopharmaceutical generic drug) company into a new drug developer. He was born on October 23, 1957, in Cheongju, Chungcheongbuk-do. He graduated from Jemulpo …
